FTC seeks more info on $16.5B Novo/Catalent deal

The request signals the agency is reviewing whether the deal could be anticompetitive under U.S. law.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...